Informatics for the Other 'Omic

Premium

Staunch metabolomicists contend that a complete map of all small-molecule metabolites in the human body would bring us much closer to where expectations have been set for personalized medicine in the 21st century than any advance in genomics or proteomics might allow. The challenge is that for all its predicted usefulness in a clinical setting, metabolomics is an exponentially more difficult problem to tackle — some researchers say that it's still not exactly clear what constitutes a complete picture of all human metabolites.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.